BrainStorm Issues 2020 Letter to Shareholders
BrainStorm Issues 2020 Letter to Shareholders USA - English Share this article Share this article NEW YORK, Dec. 28, 2020 /PRNewswire/ -- BrainStorm Cell Therapeutics Inc. (NASDAQ: BCLI), a leading developer of cellular therapies for neurodegenerative diseases, today announced the following letter from its Chief Executive Officer, Chaim Lebovits, to its shareholders and the investment community. Dear Valued Shareholders, I am incredibly proud of the tremendous progress BrainStorm made as a company in 2020. The many scientific and corporate milestones we have achieved this year are a tes...
Source: prnewswire.com